Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by canadapieton Jul 31, 2023 10:24am

89 Views

Post# 35564615

The way to ZERO

HILARIOUS!!
Stop with those stupid comments!!

Look at the reality show, the price tells you!!!

Now way under the price i sold......., even after the 1/4 reverse split!!!!!

This is a sh.t show. How can they recover???? No money, a strangling loan, no partner, selling products ?? not enough for their high salaries, costly and long trials, .......ETC!!!!!

Man o man , admit you were deadly wrong!!!! and stop with those silly arguments !!!

GLA (you will need it badly)

<< Previous

Bullboard Posts

Next >>

Drilling company poised to capitalize on market conditions